Skip to main content
. 2017 Jun 14;8(43):74209–74216. doi: 10.18632/oncotarget.18474

Figure 4. Effects of the TM6SF2 E167K and PNPLA3 I148M variants on SREBP-1c and FASN protein expression levels.

Figure 4

(A) the TM6SF2/PNPLA3-control group; (B) the TM6SF2/PNPLA3-wild type group; (C) the TM6SF2-mutant type group; (D) the PNPLA3-mutant type group; (F) the TM6SF2/PNPLA3-mutant type group. Abbreviations: SREBP-1c: sterol regulatory element-binding transcription factor 1c; FASN: fatty acid synthase; GAPDH: glyceraldehyde 3-phosphate dehydrogenase.